Who is tranylcypromine for and who needs to take extra care?
Who is tranylcypromine for?
Tranylcypromine is for adults with depression.
People who should take extra care with tranylcypromine
Make sure you tell your doctor if you have, or have had in the past, any of the following (you might need to take extra precautions, or another medicine might be more suitable):
- cardiovascular disease
- cerebrovascular disease (eg, stroke or transient ischaemic attack [TIA])
- prostatic enlargement
- bipolar disorder
- liver disease
- tumours of the adrenal gland
- blood or bone marrow disorder.
If you are over 60 years of age you may need extra monitoring for side effects and interactions if you are taking tranylcypromine.
Get advice, either directly from your doctor or from a specialist information line, about the risks of taking antidepressants if you are pregnant, breastfeeding or thinking about becoming pregnant. See Antidepressants, pregnancy and breastfeeding.
Find out more about
- What tranylcypromine does and how effective it is
- Side effects of tranylcypromine
- Interactions with tranylcypromine
- Brands of tranylcypromine
If you are starting tranylcypromine, see 10 things you should know about antidepressants.
For more information
- Starting, switching and stopping antidepressants
- Managing side effects of antidepressants
- Psychological therapies
The consumer medicine information (CMI) for your brand of tranylcypromine is available from our website or a pharmacist. The CMI includes:
- How to take this medicine
- What to do if you forget to take it
- If you take too much (overdose)
- Things you must and must not do while taking this medicine
- Signs of severe reactions and what to do.
- Rossi S, ed. eAMH [online]. Adelaide: Australian Medicines Handbook, 2012. www.amh.net.au. (Accessed 9 February 2012).
- Psychotropic Expert Group. Therapeutic Guidelines: Psychotropic, Version 6. In: eTG complete [CD-ROM]. Melbourne: Therapeutic Guidelines Limited; 2008.
- Goldshield Healthcare (Australia). Parnate consumer medicine information. 14 March 2011. (Accessed 22 March 2012).